Rizwan Afzal
Rizwan Afzal
W. L. Gore and Associates
Verified email at
Cited by
Cited by
Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ...
New England Journal of Medicine 364 (9), 806-817, 2011
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
SS Jolly, S Yusuf, J Cairns, K Niemelä, D Xavier, P Widimsky, A Budaj, ...
The Lancet 377 (9775), 1409-1420, 2011
Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
S Yusuf, SR Mehta, S Chrolavicius, R Afzal, J Pogue, CB Granger, ...
The New England journal of medicine 354 (14), 1464-1476, 2006
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
S Yusuf, K Teo, C Anderson, J Pogue, L Dyal, I Copland, H Schumacher, ...
Lancet 372 (9644), 1174-1183, 2008
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
S Yusuf, SR Mehta, S Chrolavicius, R Afzal, J Pogue, CB Granger, ...
JAMA: the journal of the American Medical Association 295 (13), 1519-1530, 2006
Early versus delayed invasive intervention in acute coronary syndromes
SR Mehta, CB Granger, WE Boden, PG Steg, JP Bassand, DP Faxon, ...
New England Journal of Medicine 360 (21), 2165-2175, 2009
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes
SR Mehta, JP Bassand, S Chrolavicius, R Diaz, JW Eikelboom, KA Fox, ...
N Engl J Med 363 (10), 930-942, 2010
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
SD Anker, A Negassa, AJS Coats, R Afzal, PA Poole-Wilson, JN Cohn, ...
The Lancet 361 (9363), 1077-1083, 2003
Dronedarone in high-risk permanent atrial fibrillation
SJ Connolly, AJ Camm, JL Halperin, C Joyner, M Alings, J Amerena, ...
New England Journal of Medicine 365 (24), 2268-2276, 2011
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionResults From the OASIS-5 Trial
SR Mehta, CB Granger, JW Eikelboom, JP Bassand, L Wallentin, ...
Journal of the American College of Cardiology 50 (18), 1742-1751, 2007
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes
A Budaj, JW Eikelboom, SR Mehta, R Afzal, S Chrolavicius, JP Bassand, ...
European heart journal 30 (6), 655-661, 2009
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction
R Díaz, A Goyal, SR Mehta, R Afzal, D Xavier, P Pais, S Chrolavicius, ...
JAMA: the journal of the American Medical Association 298 (20), 2399-2405, 2007
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux
PG Steg, SS Jolly, SR Mehta, R Afzal, D Xavier, HJ Rupprecht, ...
JAMA: The Journal of the American Medical Association 304 (12), 1339-1349, 2010
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction
A Goyal, SR Mehta, R Díaz, HC Gerstein, R Afzal, D Xavier, L Liu, P Pais, ...
Circulation 120 (24), 2429-2437, 2009
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non–ST-segment elevation acute coronary syndromes
KAA Fox, JP Bassand, SR Mehta, L Wallentin, P Theroux, LS Piegas, ...
Annals of internal medicine 147 (5), 304-310, 2007
AVERROES Steering Committee and investigators
SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ...
Apixaban in patients with atrial fibrillation. N Engl J Med 364 (9), 806-817, 2011
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention Arixtra Study in …
SR Mehta, PG Steg, CB Granger, JP Bassand, DP Faxon, JI Weitz, R Afzal, ...
Circulation 111 (11), 1390-1397, 2005
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial
RJG Peters, C Joyner, JP Bassand, R Afzal, S Chrolavicius, SR Mehta, ...
European heart journal 29 (3), 324-331, 2008
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes
JP Bassand, R Afzal, J Eikelboom, L Wallentin, R Peters, A Budaj, ...
European heart journal 31 (1), 50-58, 2010
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure
AT Yan, RT Yan, FG Spinale, R Afzal, HR Gunasinghe, M Arnold, ...
Journal of cardiac failure 12 (7), 514-519, 2006
The system can't perform the operation now. Try again later.
Articles 1–20